Skip to main content
. Author manuscript; available in PMC: 2010 Mar 17.
Published in final edited form as: N Engl J Med. 2008 Dec 10;359(26):2767–2777. doi: 10.1056/NEJMoa0807917

Table 2. Association Results in Type 1 Diabetes for CCR5 and CCR2 Variants.

Maximum 8,064 Cases and 9,339 Controls
2,519 Parent-child Trios
SNP Allele/
genotype
frequency
n (%) cases
frequency
n (%) controls
OR (95% CI) P-values
1-df
2-df
frequency
n (%) cases
frequency
n (%) parents
RR (95% CI) P-values
1-df
2-df
Combined P
1-df
2-df
3p21/CCR5 del 814 (10.33) 1,155 (11.90) 0.85 (0.80-0.92) 5.72 × 10−6 309 (10.06) 503 (10.67) 0.90 (0.75-1.09) 0.116 1.49 × 10−6
rs333 ins/ins 6,320 (80.23) 7,554 (77.83) 1.00 (reference) 2,496 (80.65) 1,887 (80.13) 1.00 (reference)
del32 ins/del 1,487 (18.88) 1,994 (20.54) 0.89 (0.82-0.96) 572 (18.48) 433 (18.39) 0.97 (0.86-1.10)
del/del 70 (0.89) 158 (1.63) 0.54 (0.40-0.72) 1.88 × 10−6 27 (0.87) 35 (1.49) 0.53 (0.34-0.82) 9.10 × 10−3 1.81 × 10−8
3p21/CCR2 A 582 (7.50) 564 (7.68) 0.97 (0.89-1.06) 0.506 N/A
rs1799864 G/G 6,641 (85.57) 6,262 (85.32) 1.00 (reference)
Ile64Val A/G 1,074 (13.86) 1,027 (13.99) 0.99 (0.90-1.08) 0.556
A/A 44 (0.57) 50 (0.68) 0.80 (0.53-1.21)

OR = odds ratio, 95% CI = 95% confidence intervals, RR = relative risk, N/A = not attempted

A 2-df test is reported as there was a significant difference between genotypic effects model and the multiplicative allelic effects model.